Skip to main content
. 2018 Dec 13;62(2):292–305. doi: 10.1007/s00125-018-4783-z

Table 2.

Associations for the top SNPs from ExWAS discovery, replication and combined meta-analyses, including Europeans and Europeans + Greenlanders, for albuminuria

SNP characteristics Discovery
n = 13,226
Replication
n = 20,759
Combined (Eur)
n = 33,985
Combined
(Eur–GL)
n = 36,590
SNP (rsID)a Gene Chr (BP) Anno EA/OA EAF
(%)
β SE p discovery EAF
(%)
n β/DOE p replication n p Eur n p Eur–GL p het
rs141640975 CUBN 10 (16992011) missense (A1690V) A/G 0. 8 0.266 0.061 1.2 × 10−5 0. 8 9742 0.279 2.9 × 10−7 22,866 1.3 × 10−11
rs10947789 KCNK5 6 (39174922) Intronic C/T 23 0.054 0.012 1.6 × 10−5 24 20,759 + 0.03 33,985 1.5 × 10−5 36,590 9.1 × 10−6 0.84
rs140177498 LMX1B 9 (129372974) Upstream T/C 0.9 0.260 0.058 8.7 × 10−6 1.1 13,233 + 0.43

SNPs with pEur/Eur–GL < 5.0 × 10−8 are novel

Discovery set is based on up to 13,226 individuals (3896 with and 9330 without diabetes)

EAF (Greenlanders, rs10947789) = 45%

EAF values are in %

β values correspond to natural log transformed albuminuria levels (ACR in mg/mmol or AER in mg/24 h)

p values are for association

aSNPs were selected for replication based on pdiscovery < 5.0 × 10−5

Anno, SNP annotation; BP, SNP position in base pairs from the Genome Reference Consortium Human Build 37 (GRCh37) in dbSNP; Chr, chromosome; DOE, direction of effect corresponding to the association summary meta-analysis based on z scores for the respective SNP; EA/OA, effect allele/other allele; ID, identity